MARGARET OLIVER: Open Payments
NPI 1770078073 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,418 in 102 payments from 13 companies in 2025. Trend: 2023 $2,358 · 2024 $2,255 · 2025 $2,418
Food & beverage: $2,418
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 22 | $581 |
| ViiV Healthcare Company | 20 | $515 |
| Insmed, Inc. | 12 | $231 |
| ABBVIE INC. | 14 | $218 |
| Merck Sharp & Dohme LLC | 10 | $180 |
| Enterra Medical, Inc. | 1 | $169 |
| Paratek Pharmaceuticals, Inc. | 9 | $136 |
| Amgen Inc. | 1 | $121 |
| Aimmune Therapeutics, Inc. | 4 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
Products named: DOVATO, Arikayce, NUZYRA, PIFELTRO, CABENUVA, DALVANCE, CUVITRU, ZENPEP.
Industry payments across AR — which companies pay providers there.
